RD
Ray Dalio (Bridgewater Associates) disclosed increased in KRYSTAL BIOTECH INC
Ray Dalio (Bridgewater Associates) filed a 13F change in KRYSTAL BIOTECH INC (501147102) on 2026-05-15, covering period end 2026-03-31.
Action
Increased
Capital
$9,508,425 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.